MGX-001 demonstrated curative FVIII activity in non-human primates Pre-IND regulatory meeting expected in Q4 2025 with investigational new drug ...
Salarius Pharmaceuticals, Inc. ("Salarius" or the "Company") (NASDAQ: SLRX) today announced the pricing of an underwritten public offering for gross proceeds of approximately $7 million before ...
According to the latest FAST scores, just 63% of third graders met Florida’s grade-level standards in math. Even fewer ...
Market Index News on MSN
The 6 best trading books for ASX investors looking to take the next step to success
From hot tips to hard lessons – six timeless trading books that show how real success comes from consistency and discipline, ...
Sylvamo Corporation offers strong value for investors seeking small-cap opportunities with solid dividends and upside ...
Shares of CoreWeave were down more than 10% in Tuesday morning trading after the company cut its full-year revenue guidance ...
Third Quarter 2025 Financial Results Net revenue in the third quarter of 2025 increased 58% to $11.8 million, compared to $7.5 million in the third quarter of 2024. The increase was due to an increase ...
Dine Brands sees Q3 2025 revenue gains but profit declines. Learn about DIN stock's key strategies, valuation insights, and ...
Developing safe AI is not just an opportunity for a democracy like ours; ever since our superpower ally checked out of its ...
Q3 2025 Earnings Call Transcript November 10, 2025 Ascend Wellness Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.13 EPS, expectations were $-0.1. Operator: Good afternoon and ...
Introduction Photobiomodulation (PBM) has shown promising effects in managing postoperative pain following conventional periapical surgery, although current evidence remains limited. This study aims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback